VR Logo

Agenus Inc. (AGEN) download report


Healthcare | Biotechnology & Pharma Research

Agenus Inc. (AGEN) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally.

IPO Date: 04-Feb-2000

Founder, Exec. Chairman & CEO: Dr. Garo H. Armen Ph.D.

VP of Fin., Principal Financial Officer & Principal Accounting Officer: Ms. Christine M. Klaskin

Listing: NASDAQ: AGEN

Country: United States

Headquarters: Lexington, MA

Website: https://www.agenusbio.com

Key Facts

Market cap: $509.46 Mln

Revenue (TTM): $309.89 Mln

Earnings (TTM): $-19.43 Mln

Cash: $262.69 Mln

Total Debt: $64.31 Mln

Insider's Holding: 10.10%

Liquidity: Low

52 Week range: $1.25 - 6.79

Shares outstanding: 270,991,008

10 Years Aggregate:

  • CFO: $-556.84 Mln
  • EBITDA: $-589.96 Mln
  • Net Profit: $-896.44 Mln

Stock Performance

Time Period Agenus (AGEN) S&P BSE Sensex* S&P Small-Cap 600*
YTD-36.65-8.83-19.22
1 month26.71-3.23-9.34
3 months-23.60-8.34-14.58
1 Year-62.361.07-17.64
3 Years-12.0610.475.91
5 Years-12.4711.475.64
10 Years-8.7411.7910.10
As on 29-Jun-2022 *As on 30-Jun-2022
Year Agenus (AGEN) S&P Small-Cap 600 S&P BSE Sensex
20211.2625.2721.99
2020-21.879.5715.75
201971.0120.8614.38
2018-26.87-9.705.87
2017-20.8711.7327.91
2016-9.2524.741.95
201514.36-3.36-5.03